Display Mode:

    Main content

    Health Information

    Congenital Heart Defects: Prostaglandins and Prostaglandin Inhibitors

    Congenital Heart Defects: Prostaglandins and Prostaglandin Inhibitors

    Skip to the navigation

    Topic Overview

    Normally, a blood vessel needed only for fetal blood circulation (called the ductus arteriosus) closes off at birth. As the fetus develops, this blood vessel is kept open by a substance in the fetus's body called prostaglandin. At birth, prostaglandin decreases and the blood vessel closes.

    In some premature infants, this blood vessel does not close. This is a condition called a patent (open) ductus arteriosus . These infants are given a prostaglandin inhibitor. It's a medicine to help the blood vessel close.

    When an infant has certain other congenital heart defects , a medicine that is a form of prostaglandin is often given by vein to keep the ductus arteriosus open. Keeping this blood vessel open allows the blood to keep moving until the defect can be fixed to allow normal blood flow. This may require surgery or another procedure.

    Related Information

    Credits

    ByHealthwise Staff
    Primary Medical Reviewer John Pope, MD - Pediatrics
    Specialist Medical Reviewer Larry A. Latson, MD - Pediatric Cardiology

    Current as ofFebruary 20, 2015

    Current as of: February 20, 2015

    This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

    © 1995-2015 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.